Breast Cancer | Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
Research To Practice | Oncology Videos · Dr. Neil Love
August 7, 20241h 14m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring an interview with Dr Joyce O'Shaughnessy, including the following topics:
- Overview of CDK Inhibition for Metastatic Breast Cancer (0:00)
- Features of High-Risk, HR-Positive, HER2-Negative Localized Breast Cancer (7:45)
- Sequencing and Selection of CDK4/6 Inhibitors (23:28)
- Management of Toxicities Associated with CDK Inhibitors and Promoting Patient Adherence (45:47)
- Review of Clinical Investigator Survey Results (1:01:47)